{"result": {"id": "chatcmpl-114", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**ANLOTINIB** is a drug used to treat lung cancer.  It is a multitarget tyrosine kinase inhibitor that inhibits EphA2, and has also been shown to potentially reverse crizotinib resistance in some cases. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743185903, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 50, "prompt_tokens": 216, "total_tokens": 266, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"ANLOTINIB\"\nDescription List: [\"**ANLOTINIB** is a drug used to treat lung cancer.  It is an anti-angiogenic drug that has also been shown to potentially reverse crizotinib resistance in some cases. \\n\", \"**Anlotinib** is a novel multitarget tyrosine kinase inhibitor. It inhibits EphA2 and is used to treat cancer. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_8cf0f32a70b5c73646b18a9365cb6d2f8e888f9ab0f692fe43b0512b1dce4635_v2"}